Publicaciones en las que colabora con José Juan Rifón Roca (20)

2019

  1. Differences in Venous Thromboembolism Prevention and Outcome between Hospitalized Patients with Solid and Hematologic Malignancies

    TH Open

2017

  1. First-line use of rituximab correlates with increased overall survival in late post-transplant lymphoproliferative disorders: retrospective, single-centre study

    European Journal of Haematology, Vol. 98, Núm. 1, pp. 38-43

1999

  1. Measurement of prethrombotic markers in the assessment of acquired hypercoagulable states

    Thrombosis Research, Vol. 93, Núm. 2, pp. 71-78

1997

  1. The increase of plasminogen activator inhibitor activity is associated with graft occlusion in patients undergoing aorto-coronary bypass surgery

    British Journal of Haematology, Vol. 99, Núm. 2, pp. 262-267

1996

  1. Different fibrinolytic profile in orthopedic and abdominal surgery

    Fibrinolysis, Vol. 10, Núm. SUPPL. 3, pp. 132

1995

  1. Increased concentrations of tumor necrosis factor and lnterleukin-6 contribute to the hemostatic abnormalities in advanced liver disease

    Pathophysiology of Haemostasis and Thrombosis, Vol. 25, Núm. 6, pp. 305-311

1994

  1. Indications for bone marrow transplantation

    Revista de medicina de la Universidad de Navarra, Vol. 38, Núm. 4, pp. 212-225

  2. Thrombin-antithrombin complexes and prothrombin fragment 1+2 in aorto-coronary bypass surgery: Relation to graft occlusion

    Hematologic Pathology, Vol. 8, Núm. 1-2, pp. 35-42

1993

  1. ALTERACIONES DE LA HEMOSTASIA EN CIRUGIA EXTRACORPOREA: PATOGENESIS Y TRATAMIENTO

    Sangre, Vol. 38, Núm. 3, pp. 225-231

  2. ASOCIACION DE POLICITEMIA VERA Y MIELOMA MULTIPLE. PRESENTACION DE UN NUEVO CASO Y REVISION DE LA LITERATURA

    Sangre, Vol. 38, Núm. 6, pp. 497-499

1992

  1. COAGULACION INTRAVASCULAR DISEMINADA INDUCIDA POR ENDOTOXINA EN CONEJOS: EFECTO DEL TRATAMIENTO CON T-PA Y UROQUINASA

    Sangre, Vol. 37, Núm. 6, pp. 435-438

  2. Thrombin-antithrombin complexes and F1+2 prothrombin fragment in coronary revascularization surgery. Relationship with graft occlusion

    Sangre, Vol. 37, Núm. 4, pp. 259-263

1991

  1. Intra- and postoperative fibrinolysis in patients undergoing cardiopulmonary bypass surgery

    Haemostasis, Vol. 21, Núm. 1, pp. 58-64

  2. Thrombin activation and increased fibrinolysis in patients with chronic liver disease.

    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, Vol. 2, Núm. 2, pp. 227-230

1990

  1. CONCENTRACION PLASMATICA DE FIBRONECTINA EN PACIENTES NEOPLASICOS

    Revista de Diagnostico Biologico, Vol. 39, Núm. 3, pp. 106-108

  2. Fibrinogen and fibrin degradation products in patients undergoing open-heart surgery.

    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, Vol. 1, Núm. 4-5, pp. 509-512

  3. TERAPEUTICA TROMBOLITICA EN EL INFARTO AGUDO DE MIOCARDIO

    Clinica Cardiovascular, Vol. 8, Núm. 1, pp. 7-16

1989

  1. Anomalías moleculares congénitas del fibrinógeno y de la protrombina.

    Sangre, Vol. 34, Núm. 3, pp. 210-220

  2. Clotting activation and impairment of fibrinolysis in malignancy

    Thrombosis Research, Vol. 54, Núm. 6, pp. 699-707

  3. Inhibidores de la coagulación en pacientes neoplásicos.

    Medicina Clinica, Vol. 92, Núm. 5, pp. 164-166